ANNX Annexon, Inc. - common stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 12, 2026
$4,19
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$2,54rendah 52m
$7,18tinggi 52m
Kapitalisasi Pasar
$626M
P/E
-3.1
EPS
$-1.34
lencana Anda
Rentang 52M
$3–$7
Peringkat Analis
BUY
Target Harga
$15
P/E
-3.1
ROE
-100.7%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ANNX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.19
Kapitalisasi Pasar
$626M
P/E
-3.1
EPS
$-1.34
ROE
-100.7%
Rentang 52M
$3–$7
ANNX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-1.342021-12-31 → 2025-12-31
Arus Kas Bebas$-186M2020-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ANNX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -3.1rata-rata 5T ≈-3.4 | ≈-3.4 | · | · | |
| P/B | 3.0rata-rata 5T ≈2.0 | ≈2.0 | 3.3 | Nilai wajar | |
| Price / FCF (Harga / FCF) | -3.4rata-rata 5T ≈-3.6 | ≈-3.6 | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -3.4rata-rata 5T ≈-3.6 | ≈-3.6 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 3.0rata-rata 5T ≈2.0 | ≈2.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ANNX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -65.9%rata-rata 5T ≈-49.0% | ≈-49.0% | -45.7% | Lemah | |
| ROE | -100.7%rata-rata 5T ≈-64.2% | ≈-64.2% | -51.4% | Lemah | |
| ROIC | -102.2%rata-rata 5T ≈-70.7% | ≈-70.7% | -47.7% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ANNX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 5.5rata-rata 5T ≈10.7 | ≈10.7 | 6.1 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 3.8rata-rata 5T ≈5.5 | ≈5.5 | 4.6 | Sejajar |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-3.0%
Laporan Berikutnya
Nov 09, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 17, 2026 | $-0.28 | $-0.24 | -14.8% |
| 31 Maret 2026 | Mei 18, 2026 | $-0.23 | $-0.29 | 22.0% |
| 31 Des. 2025 | $-0.28 | $-0.32 | 12.2% | |
| 30 Sep. 2025 | $-0.37 | $-0.35 | -6.7% | |
| 30 Juni 2025 | $-0.34 | $-0.37 | 8.8% | |
| 31 Maret 2025 | $-0.37 | $-0.30 | -22.4% | |
| 31 Des. 2024 | $-0.33 | $-0.27 | -20.2% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $185M | $119M | $114M | $113M | $100M | $49M | $25M | |
| SG&A Expense | $32M | $35M | $30M | $33M | $31M | $14M | $8M | |
| Operating Expenses | $216M | $154M | $144M | $146M | $131M | $63M | $33M | |
| Operating Income | $-216M | $-154M | $-144M | $-146M | $-131M | $-63M | $-33M | |
| Other Non-op | · | · | · | · | · | $57.0K | $1M | |
| Pretax Income | $-207M | $-138M | $134M | $142M | $130M | $-63M | $-37M | |
| Income Tax | $0 | $0 | $0 | $0 | · | · | $4.0K | |
| Net Income | $-207M | $-138M | $-134M | $-142M | $-130M | $-63M | $-37M | |
| EPS (Basic) | $-1.34 | $-1.01 | $-1.77 | $-2.60 | $-3.40 | · | · | |
| EPS (Diluted) | $-1.34 | $-1.01 | $-1.77 | $-2.60 | $-3.40 | · | · | |
| Shares (Basic) | 155,105,832 | 137,404,145 | 75,673,081 | 54,673,572 | 38,316,273 | · | · | |
| Shares (Diluted) | 155,105,832 | 137,404,145 | 75,673,081 | 54,673,572 | 38,316,273 | · | · | |
| EBITDA | $-214M | $-152M | $-142M | $-143M | $-129M | $-63M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $162M | $49M | $225M | $140M | $75M | $269M | $44M | |
| Prepaid Expense | $4M | $4M | $4M | $5M | $5M | $3M | $1M | |
| Other Current Assets | · | · | $63.0K | $203.0K | $463.0K | $3.0K | $79.0K | |
| Current Assets | $242M | $316M | $264M | $248M | $248M | $354M | $45M | |
| PP&E (Net) | $11M | $13M | $15M | $17M | $18M | $2M | $2M | |
| PP&E (Gross) | $20M | $20M | $20M | $20M | $19M | $4M | $3M | |
| Accum. Depreciation | $9M | $7M | $5M | $3M | $789.0K | $2M | $1M | |
| Other Non-current Assets | $9M | $3M | · | · | · | · | $2M | |
| Total Assets | $278M | $350M | $298M | $285M | $287M | $356M | $50M | |
| Accounts Payable | $15M | $10M | $5M | $7M | $11M | $4M | $2M | |
| Accrued Liabilities | · | · | $10M | $13M | $9M | $6M | $2M | |
| Current Liabilities | $43M | $31M | $18M | $22M | $22M | $11M | $5M | |
| Capital Leases | $23M | $26M | $29M | $32M | $33M | · | · | |
| Total Liabilities | $66M | $57M | $47M | $54M | $55M | $12M | $6M | |
| Common Stock | $149.0K | $109.0K | $78.0K | $48.0K | $39.0K | $38.0K | $4.0K | |
| Paid-in Capital | $1.13B | $1.00B | $823M | $670M | $528M | $510M | $2M | |
| Retained Earnings | $-917M | $-711M | $-572M | $-438M | $-296M | $-166M | $-103M | |
| AOCI | $-29.0K | $10.0K | $-52.0K | $-372.0K | $-180.0K | $-77.0K | $-80.0K | |
| Stockholders' Equity | $212M | $293M | $251M | $231M | $232M | $344M | $-100M | |
| Liabilities + Equity | $278M | $350M | $298M | $285M | $287M | $356M | $50M | |
| Shares Outstanding | 149,362,800 | 109,381,556 | 78,369,099 | 47,722,995 | 38,560,854 | 38,157,618 | 433,749 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $667.0K | $493.0K | |
| Stock-based Comp | $16M | $19M | $18M | $19M | $16M | $5M | $2M | |
| Other Non-cash | $2M | $-1M | $-7M | $5M | $6M | $5M | · | |
| Operating Cash Flow | $-186M | $-118M | $-121M | $-116M | $-106M | $-53M | $-28M | |
| CapEx | $137.0K | $15.0K | $193.0K | $7M | $2M | $464.0K | $267.0K | |
| Investing Cash Flow | $190M | $-219M | $71M | $58M | $-88M | $-83M | $-267.0K | |
| Stock Issued | $28M | $44M | $18M | · | · | · | · | |
| Net Stock Activity | $28M | $44M | · | · | · | · | · | |
| Financing Cash Flow | $109M | $161M | $136M | $123M | $2M | $361M | $28M | |
| Free Cash Flow | $-186M | $-118M | $-121M | $-123M | $-108M | $-54M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -65.9% | -42.7% | -46.1% | -49.6% | -40.5% | -31.2% | · | |
| ROE | -100.7% | -44.2% | -65.9% | -57.7% | -52.5% | -17.9% | · | |
| ROIC | -102.2% | -52.6% | -57.4% | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 10.4 | 14.7 | 11.1 | 11.4 | 33.3 | · | |
| Quick Ratio | 3.8 | 1.6 | 12.6 | 6.3 | 3.4 | 25.3 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.42 | $2.68 | $3.20 | $4.84 | $6.01 | $9.02 | · | |
| Cash Flow / Share | $-1.20 | $-0.86 | $-1.60 | $-2.13 | · | · | · | |
| Cash / Share | $1.08 | $0.45 | $2.87 | $2.93 | $1.94 | $7.04 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | |
| EPS (TTM) | $-1.34 | $-1.01 | $-1.77 | $-2.60 | $-3.40 | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-207M | $-138M | $-134M | $-142M | $-130M | $-63M | · | |
| Market Cap | $750M | $561M | $356M | $247M | $443M | $955M | · | |
| P/E | -3.7 | -5.1 | -2.6 | -2.0 | -3.4 | · | · | |
| P/B | 3.5 | 1.9 | 1.4 | 1.1 | 1.9 | 2.8 | · | |
| P / Tangible Book | 3.5 | 1.9 | 1.4 | 1.1 | 1.9 | 2.8 | · | |
| P / Cash Flow | -4.0 | -4.8 | -2.9 | -2.1 | -4.2 | -18.0 | · | |
| P / FCF | -4.0 | -4.8 | -2.9 | -2.0 | -4.1 | -17.8 | · | |
| Earnings Yield | -26.7% | -19.7% | -39.0% | -50.3% | -29.6% | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $36M | $43M | $50M | $44M | $48M | $43M | $30M | $25M | $21M | $23M | $28M | $30M | $32M | $29M | $28M | |
| SG&A Expense | $11M | $10M | $8M | $7M | $8M | $9M | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $9M | $8M | $8M | |
| Operating Expenses | $57M | $46M | $50M | $57M | $52M | $57M | $52M | $39M | $34M | $29M | $30M | $35M | $38M | $41M | $37M | $36M | |
| Operating Income | $-57M | $-46M | $-50M | $-57M | $-52M | $-57M | $-52M | $-39M | $-34M | $-29M | $-30M | $-35M | $-38M | $-41M | $-37M | $-36M | |
| Net Income | $-55M | $-44M | $-48M | $-55M | $-49M | $-54M | $-49M | $-35M | $-30M | $-25M | $-28M | $-32M | $-35M | $-39M | $-34M | $-35M | |
| EPS (Basic) | $-0.28 | $-0.23 | $-0.26 | $-0.37 | $-0.34 | $-0.37 | $-0.32 | $-0.25 | $-0.23 | $-0.21 | $-0.35 | $-0.43 | $-0.47 | $-0.52 | $-0.21 | $-0.51 | |
| EPS (Diluted) | $-0.28 | $-0.23 | $-0.26 | $-0.37 | $-0.34 | $-0.37 | $-0.32 | $-0.25 | $-0.23 | $-0.21 | $-0.35 | $-0.43 | $-0.47 | $-0.52 | $-0.21 | $-0.51 | |
| Shares (Basic) | 201,003,269 | 194,200,100 | · | 149,123,701 | 148,320,803 | 148,108,809 | · | 139,933,019 | 130,132,960 | 122,673,202 | · | 75,342,495 | 75,230,003 | 73,855,642 | · | 68,652,859 | |
| Shares (Diluted) | 201,003,269 | 194,200,100 | · | 149,123,701 | 148,320,803 | 148,108,809 | · | 139,933,019 | 130,132,960 | 122,673,202 | · | 75,342,495 | 75,230,003 | 73,855,642 | · | 68,652,859 | |
| EBITDA | $-57M | $-46M | · | $-57M | $-52M | $-57M | · | $-39M | $-34M | $-28M | · | $-35M | $-38M | $-41M | · | $-36M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $199M | $175M | $162M | $139M | $132M | $97M | $49M | $80M | $157M | $152M | $225M | $133M | $114M | $144M | $140M | $211M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $6M | $4M | $4M | $5M | $4M | $5M | $5M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $23.0K | · | $13.0K | $167.0K | $165.0K | $203.0K | $57.0K | |
| Current Assets | $213M | $228M | $242M | $193M | $231M | $268M | $316M | $344M | $374M | $271M | $264M | $169M | $198M | $233M | $248M | $275M | |
| PP&E (Net) | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | $14M | $15M | $15M | $16M | $16M | $17M | $17M | |
| PP&E (Gross) | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $20M | $19M | |
| Accum. Depreciation | $10M | $10M | $9M | $9M | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Other Non-current Assets | $8M | $9M | $9M | $9M | $5M | $5M | $3M | $3M | · | $361.0K | · | · | · | $12.0K | · | $204.0K | |
| Total Assets | $246M | $263M | $278M | $229M | $265M | $303M | $350M | $379M | $406M | $304M | $298M | $204M | $233M | $269M | $285M | $313M | |
| Accounts Payable | $16M | $18M | $15M | $18M | $12M | $10M | $10M | $7M | $4M | $4M | $5M | $5M | $7M | $10M | $7M | $7M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $11M | $7M | · | $10M | $9M | $11M | $13M | $11M | |
| Current Liabilities | $38M | $36M | $43M | $44M | $41M | $34M | $31M | $20M | $17M | $13M | $18M | $17M | $18M | $23M | $22M | $20M | |
| Capital Leases | $22M | $22M | $23M | $24M | $25M | $26M | $26M | $27M | $28M | $29M | $29M | $30M | $30M | $31M | $32M | $32M | |
| Total Liabilities | $60M | $58M | $66M | $68M | $66M | $59M | $57M | $47M | $45M | $42M | $47M | $47M | $48M | $54M | $54M | $52M | |
| Common Stock | $175.0K | $162.0K | $149.0K | $115.0K | $110.0K | $109.0K | $109.0K | $106.0K | $106.0K | $90.0K | $78.0K | $53.0K | $53.0K | $53.0K | $48.0K | $48.0K | |
| Paid-in Capital | $1.20B | $1.17B | $1.13B | $1.03B | $1.01B | $1.01B | $1.00B | $993M | $988M | $860M | $823M | $702M | $697M | $692M | $670M | $665M | |
| Retained Earnings | $-1.02B | $-962M | $-917M | $-869M | $-814M | $-765M | $-711M | $-662M | $-627M | $-598M | $-572M | $-545M | $-512M | $-477M | $-438M | $-404M | |
| AOCI | $-82.0K | $-81.0K | $-29.0K | $-76.0K | $-93.0K | $-91.0K | $10.0K | $77.0K | $-89.0K | $-102.0K | $-52.0K | $-123.0K | $-171.0K | $-217.0K | $-372.0K | $-406.0K | |
| Stockholders' Equity | $186M | $205M | $212M | $161M | $199M | $244M | $293M | $332M | $361M | $262M | $251M | $157M | $185M | $215M | $231M | $261M | |
| Liabilities + Equity | $246M | $263M | $278M | $229M | $265M | $303M | $350M | $379M | $406M | $304M | $298M | $204M | $233M | $269M | $285M | $313M | |
| Shares Outstanding | · | · | 149,362,800 | · | · | · | 109,381,556 | · | · | · | 78,369,099 | · | · | · | 47,722,995 | · |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $540.0K | $539.0K | $543.0K | $546.0K | $540.0K | $537.0K | $537.0K | $538.0K | $537.0K | $538.0K | $538.0K | $538.0K | $536.0K | $536.0K | $530.0K | $518.0K | |
| Stock-based Comp | $5M | $4M | $3M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-7M | · | · | · | $-1M | · | · | · | $-8M | · | · | · | $540.0K | · | · | |
| Operating Cash Flow | $-48M | $-47M | $-46M | $-52M | $-38M | $-50M | $-36M | $-32M | $-22M | $-28M | $-23M | $-28M | $-36M | $-33M | $-27M | $-31M | |
| CapEx | $137.0K | $0 | $0 | $48.0K | $15.0K | $74.0K | $6.0K | · | · | · | $7.0K | $19.0K | $30.0K | $137.0K | $282.0K | $169.0K | |
| Investing Cash Flow | $40M | $27M | $-27M | $46M | $73M | $98M | $1M | $-46M | $-97M | $-77M | $-2M | $48M | $6M | $20M | $-44M | $14M | |
| Stock Issued | $32M | $34M | $14M | $14M | $0 | $0 | $5M | $0 | $7M | $33M | $0 | $450.0K | $450.0K | $18M | · | · | |
| Net Stock Activity | · | $34M | · | · | · | · | · | · | · | $33M | · | · | · | $18M | · | · | |
| Financing Cash Flow | $32M | $33M | $95M | $14M | $153.0K | $59.0K | $5M | $175.0K | $124M | $32M | $118M | $0 | $345.0K | $18M | $108.0K | $123M | |
| Free Cash Flow | · | $-47M | · | · | · | $-50M | · | · | · | · | · | · | · | $-33M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.7% | -15.6% | · | -18.1% | -14.7% | -17.9% | · | -11.9% | -9.3% | -9.1% | · | -13.8% | -15.5% | · | · | -11.3% | |
| ROE | -28.7% | -19.7% | · | -22.3% | -17.5% | -21.5% | · | -14.3% | -10.8% | -10.9% | · | -17.5% | -20.0% | · | · | -13.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 6.4 | · | 4.4 | 5.7 | 8.0 | · | 17.2 | 21.8 | 20.6 | · | 9.9 | 11.0 | · | · | 13.6 | |
| Quick Ratio | 5.2 | 4.9 | · | 3.2 | 3.3 | 2.9 | · | 4.0 | 9.2 | 11.6 | · | 7.8 | 6.4 | · | · | 10.4 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-0.24 | · | · | · | $-0.34 | · | · | · | $-0.23 | · | · | · | $-0.45 | · | · | |
| EPS (TTM) | $-1.14 | $-1.20 | · | $-1.40 | $-1.28 | $-1.17 | · | $-1.04 | $-1.22 | $-1.46 | · | $-1.63 | $-1.71 | $-2.20 | · | $-3.36 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-203M | $-196M | · | $-207M | $-187M | $-167M | · | $-118M | $-115M | $-121M | · | $-141M | $-143M | $-145M | · | $-145M | |
| P/E | -5.0 | -4.6 | · | -2.2 | -1.9 | -1.6 | · | -5.7 | -4.0 | -4.9 | · | -1.4 | -2.1 | -1.8 | · | -1.8 | |
| Earnings Yield | -20.0% | -21.7% | · | -45.9% | -53.3% | -60.6% | · | -17.6% | -24.9% | -20.4% | · | -69.1% | -48.6% | -57.1% | · | -54.4% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-207M | $-138M | $-134M | $-142M | $-130M |
| EPS Dilusian | $-1.34 | $-1.01 | $-1.77 | $-2.60 | $-3.40 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 5.7 | 10.4 | 14.7 | 11.1 | 11.4 |
| Rasio Cepat | 3.8 | 1.6 | 12.6 | 6.3 | 3.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-186M | $-118M | $-121M | $-123M | $-108M |
Pemilik institusional (13F) 230 pengaju · $1.1B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
230
Nilai yang dipegang
$1.1B
Posisi baru
34
Posisi yang keluar
27
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 34 (-34 vs Kuartal sebelumnya) | 27 (+12 vs Kuartal sebelumnya) | 81 (-9 vs Kuartal sebelumnya) | 78 (+30 vs Kuartal sebelumnya) | +26.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $111.450.614 | 19.518.496 | 10,53% | Saham |
| BlackRock, Inc. | $77.311.938 | 13.539.744 | 7,31% | Saham |
| Redmile Group, LLC | $67.776.998 | 11.869.877 | 6,41% | Saham |
| STATE STREET CORP | $56.096.873 | 9.824.321 | 5,30% | Saham |
| BVF INC/IL | $49.666.568 | 8.698.173 | 4,69% | Saham |
| Woodline Partners LP | $39.542.133 | 6.925.067 | 3,74% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $39.233.496 | 6.871.015 | 3,71% | Saham |
| VANGUARD GROUP INC | $38.922.003 | 7.753.387 | 3,68% | Saham |
| MAK CAPITAL ONE LLC | $33.473.048 | 5.862.180 | 3,16% | Saham |
| GOLDMAN SACHS GROUP INC | $33.264.057 | 5.825.579 | 3,14% | Saham |
| Siren, L.L.C. | $25.458.869 | 4.458.646 | 2,41% | Saham |
| Bain Capital Life Sciences Investors, LLC | $25.339.444 | 4.437.731 | 2,39% | Saham |
| Bellevue Group AG | $23.411.091 | 4.100.016 | 2,21% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $23.056.071 | 4.037.193 | 2,18% | Saham |
| MPM BIOIMPACT LLC | $20.238.261 | 3.544.354 | 1,91% | Saham |
| AMERIPRISE FINANCIAL INC | $20.039.948 | 3.509.623 | 1,89% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $19.985.000 | 3.500.000 | 1,89% | Saham |
| GREAT POINT PARTNERS LLC | $19.985.000 | 3.500.000 | 1,89% | Saham |
| MORGAN STANLEY | $17.954.827 | 3.144.453 | 1,70% | Saham |
| Palo Alto Investors LP | $16.833.594 | 2.948.090 | 1,59% | Saham |
| Balyasny Asset Management L.P. | $16.164.873 | 2.830.976 | 1,53% | Saham |
| Nuveen, LLC | $15.788.607 | 2.765.080 | 1,49% | Saham |
| Qube Research & Technologies Ltd | $15.702.277 | 2.749.961 | 1,48% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.829.228 | 2.246.800 | 1,21% | Saham |
| Opaleye Management Inc. | $9.789.515 | 1.714.451 | 0,93% | Saham |
| Logos Global Management LP | $8.565.000 | 1.500.000 | 0,81% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $8.550.585 | 1.497.756 | 0,81% | Saham |
| Point72 Asset Management, L.P. | $7.895.211 | 1.382.699 | 0,75% | Saham |
| NORTHERN TRUST CORP | $7.720.182 | 1.352.046 | 0,73% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.182.032 | 1.257.799 | 0,68% | Saham |
| Tetragon Partners GP Ltd | $7.094.418 | 1.242.455 | 0,67% | Saham |
| Candriam S.C.A. | $6.817.695 | 1.195.142 | 0,64% | Saham |
| MILLENNIUM MANAGEMENT LLC | $6.765.956 | 1.184.931 | 0,64% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $6.312.120 | 1.105.450 | 0,60% | Saham |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $5.923.360 | 1.037.366 | 0,56% | Saham |
| JPMORGAN CHASE & CO | $5.593.995 | 1.004.308 | 0,53% | Saham |
| WELLS FARGO & COMPANY/MN | $5.584.694 | 978.055 | 0,53% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $5.526.857 | 967.926 | 0,52% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $5.129.830 | 898.394 | 0,48% | Saham |
| Ishara Investments LP | $4.682.200 | 820.000 | 0,44% | Saham |
| Ensign Peak Advisors, Inc | $4.570.946 | 800.516 | 0,43% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4.213.609 | 737.935 | 0,40% | Saham |
| Y-Intercept (Hong Kong) Ltd | $4.194.480 | 734.585 | 0,40% | Saham |
| Russell Investments Group, Ltd. | $4.027.213 | 705.291 | 0,38% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $3.950.245 | 691.812 | 0,37% | Saham |
| Parkman Healthcare Partners LLC | $3.660.276 | 641.029 | 0,35% | Saham |
| UBS Group AG | $3.557.866 | 623.094 | 0,34% | Saham |
| DEUTSCHE BANK AG\ | $3.520.153 | 616.489 | 0,33% | Saham |
| BANK OF AMERICA CORP /DE/ | $3.507.002 | 614.186 | 0,33% | Saham |
| CITADEL ADVISORS LLC | $3.406.483 | 596.582 | 0,32% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Satter Muneer A | 21 Nov. 2025 | 7,20% | Amandemen | · | SEC |
| Muneer A. Satter ×2 pengajuan | 17 Feb. 2023 | · | Pengajuan awal | · | SEC |
| Clarus Lifesciences III, L.P., Clarus Ventures III GP, L.P., Blackstone Clarus III L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., Blackstone Inc., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×2 pengajuan | 27 Agu 2021 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 17 orang dalam · 8 pejabat · 10 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Douglas Love | PRESIDENT AND CEO | 24 Sep. 2026 P | 390.476 | 1 | 0 | $99.829 |
| Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 2 Maret 2026 S | 170.700 | 0 | 2 | $-70.281 |
| Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 11 Juni 2026 M | 184.807 | 0 | 2 | $-70.317 |
| Dean Richard Artis | EVP & CHIEF SCIENTIFIC OFFICER | 2 Maret 2026 S | 180.093 | 0 | 2 | $-58.983 |
| Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 2 Maret 2026 S | 182.625 | 0 | 2 | $-55.265 |
| Jamie Dananberg | CHIEF MEDICAL OFFICER | 2 Maret 2026 S | 123.582 | 0 | 2 | $-58.582 |
| Larry Mattheakis | EVP & Chief Scientific Officer | 11 Juli 2022 A | 17.188 | 0 | 0 | $0 |
| Sanjay Chandru Keswani | EVP & Chief Medical Officer | 11 Feb. 2022 A | 12.500 | 0 | 0 | $0 |
| Mark S. Blumenkranz | Direktur | 10 Agu 2026 A | · | 0 | 0 | $0 |
| Bettina M. Cockroft | Direktur | 11 Juni 2026 A | · | 0 | 0 | $0 |
| William H. Carson | Direktur | 11 Juni 2026 A | 78.405 | 6 | 0 | $193.296 |
| Jung Choi | Direktur | 11 Juni 2026 A | 33.000 | 1 | 0 | $138.270 |
| William D. Waddill | Direktur | 11 Juni 2026 A | · | 0 | 0 | $0 |
| William A Jones JR | Direktur | 11 Juni 2026 A | · | 0 | 0 | $0 |
| Satter Muneer A | Direktur | 11 Juni 2026 A | 10.342.134 | 6 | 0 | $11.974.803 |
| Thomas G Wiggans | Direktur | 5 Juni 2025 A | · | 0 | 0 | $0 |
| Ricky Sun | Direktur | 2 Juni 2021 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 31 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,72% | 65.989 NS | 31 Juli 2026 | N-PORT |
| IBRN · iShares Trust | 0,62% | 11.173 SH | 11 Sep. 2026 | Harian |
| LABU · Direxion Shares ETF Trust | 0,22% | 211.825 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,15% | 529.206 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,13% | 451.913 SH | 19 Agu 2026 | Harian |
| FFSM · FIDELITY COVINGTON TRUST | 0,11% | 311.203 NS | 31 Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,06% | 2.894 NS | 31 Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 37.296 SH | 2 Okt. 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 13.416 SH | 2 Okt. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 166.500 SH | 19 Agu 2026 | Harian |
| IBB · iShares Trust | 0,05% | 1.238.553 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,04% | 1.460.473 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 206.316 SH | 2 Okt. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 893.974 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,03% | 74.211 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 3.987.933 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,01% | 326.558 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.754.465 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 366.971 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 56.295 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 7.332 SH | 11 Sep. 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,00% | 15.800 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 218.518 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 54.863 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 219.924 SH | 11 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 19.704 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 22.484 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.970.636 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.754 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 6.291 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 31.162 SH | 11 Sep. 2026 | Harian |
ANNX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 17 analis
BELI
Target median
$14.00
+234,1%
4 23,5%
Beli Kuat
10 58,8%
Beli
3 17,6%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
7 analis · 2026-09-28Target rata-rata $15.29 +264,8%
← Di bawah semua target
Harga saat ini $4.19
Rendah$7.00
Rata-rata$15.29
Tinggi$27.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| OBX | · | · | · | · | · | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| ACHV | · | -4.0 | · | · | · | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 12, 2026